<bill session="113" type="h" number="2985" updated="2013-11-02T06:44:09-04:00">
  <state datetime="2013-08-02">REFERRED</state>
  <status>
    <introduced datetime="2013-08-02"/>
  </status>
  <introduced datetime="2013-08-02"/>
  <titles>
    <title type="short" as="introduced">Combination Drug Development Incentive Act of 2013</title>
    <title type="official" as="introduced">To amend section 505 of the Federal Food, Drug, and Cosmetic Act to provide incentives for the development of new combination drugs.</title>
  </titles>
  <sponsor id="412270"/>
  <cosponsors>
    <cosponsor id="400076" joined="2013-08-02"/>
    <cosponsor id="400606" joined="2013-08-02"/>
  </cosponsors>
  <actions>
    <action datetime="2013-08-02" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2013-08-02">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Prescription drugs"/>
    <term name="Product development and innovation"/>
  </subjects>
  <amendments/>
</bill>
